Vaccines against dengue virus (DV) are commercially nonexistent. A subunit vaccination strategy may be of value, especially if a safe viral vector acts as biologically active adjuvant. In this paper, we focus on an immunoglobulin-like, independently folded domain III (DIII) from DV 2 envelope protein (E), which contains epitopes that elicits highly specific neutralizing antibodies.
Download count: 0
- Harahap, Indira (Author)
- Ceballos-Olvera, Ivonne (Author)
- Reyes del Valle, Jorge (Author)
- College of Liberal Arts and Sciences (Contributor)
- Digital object identifier: 10.3390/vaccines3030503
- Identifier TypeInternational standard serial numberIdentifier Value2076-393X
Citation and reuse
Cite this item
This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.
Harahap-Carrillo, I., Ceballos-Olvera, I., & Valle, J. (2015). Immunogenic Subviral Particles Displaying Domain III of Dengue 2 Envelope Protein Vectored by Measles Virus. Vaccines, 3(3), 503-518. doi:10.3390/vaccines3030503